2023 Oregon Revised Statutes › Volume : 09 - Education and Culture › Chapter 339 - School Attendance; Admission; Discipline; Safety › Section 339.869 - Administration of medication and short-acting opioid antagonists; information to parents; rules.

(1) The State Board of Education, in consultation with the Oregon Health Authority, the Oregon State Board of Nursing and the State Board of Pharmacy, shall adopt:
(a) Rules for the administration of prescription and nonprescription medication to students by trained school personnel and for student self-medication. The rules shall include age appropriate guidelines and training requirements for school personnel.
(b) Rules for the administration of premeasured doses of epinephrine by school personnel trained as provided by ORS 433.815 to any student or other individual on school premises who the personnel believe in good faith is experiencing a severe allergic reaction, regardless of whether the student or individual has a prescription for epinephrine.
(c)(A) Rules for the administration of medication that treats adrenal insufficiency by school personnel trained as provided by ORS 433.815 to any student on school premises whose parent or guardian has provided for the personnel the medication as described in ORS 433.825 (3) and who the personnel believe in good faith is experiencing an adrenal crisis, as defined in ORS 433.800.
(B) Rules adopted under this paragraph must:
(i) Include guidelines on the designation and training of school personnel who will be responsible for administering medication; and
(ii) Specify that a school district is only required to train school personnel when the school district has been notified by a parent or guardian that a student enrolled in a school of the school district has been diagnosed with adrenal insufficiency.
(d) Guidelines for the management of students with life-threatening food allergies and adrenal insufficiency, which must include:
(A) Standards for the education and training of school personnel to manage students with life-threatening allergies or adrenal insufficiency.
(B) Procedures for responding to life-threatening allergic reactions or an adrenal crisis, as defined in ORS 433.800.
(C) A process for the development of individualized health care and allergy or adrenal insufficiency plans for every student with a known life-threatening allergy or adrenal insufficiency.
(D) Protocols for preventing exposures to allergens.
(e) Rules for the administration of a short-acting opioid antagonist to any student or other individual on school premises who the individual administering the short-acting opioid antagonist believes in good faith is experiencing an opioid overdose.
(2)(a) School district boards shall adopt policies and procedures that provide for:
(A) The administration of prescription and nonprescription medication to students by trained school personnel, including the administration of medications that treat adrenal insufficiency;
(B) Student self-medication; and
(C) The administration of premeasured doses of epinephrine to students and other individuals.
(b) Policies and procedures adopted under paragraph (a) of this subsection shall be consistent with the rules adopted by the State Board of Education under subsection (1) of this section. A school district board shall not require school personnel who have not received appropriate training to administer medication.
(3)(a) School district boards may adopt policies and procedures that provide for the administration of a short-acting opioid antagonist.
(b) Policies and procedures adopted under paragraph (a) of this subsection shall be consistent with the rules adopted by the State Board of Education under subsection (1) of this section.
(4)(a) A school district board shall provide to the parent or legal guardian of each minor student enrolled in a school in the school district information regarding short-acting opioid antagonists. The information described in this subsection must include at least:
(A) A description of short-acting opioid antagonists and their purpose;
(B) A statement regarding, in an emergency situation, the risks of administering to an individual a short-acting opioid antagonist and the risks of not administering to an individual a short-acting opioid antagonist;
(C) A statement that all schools within the school district have access to short-acting opioid antagonists and the necessary medical supplies to administer the short-acting opioid antagonist on site; and
(D) A statement that a representative of a school may administer to a student a short-acting opioid antagonist in an emergency if the student appears to be unconscious and experiencing an opioid overdose.
(b) A school district board shall ensure that the parent or legal guardian of a minor student enrolled in a school within the school district is immediately notified when a short-acting opioid antagonist is administered to the student if the short-acting opioid antagonist is administered while the student is at school, on school property under the jurisdiction of the school district or at any activity under the jurisdiction of the school district. [1997 c.144 §4; 2009 c.595 §214; 2013 c.486 §2; 2015 c.676 §2; 2019 c.375 §2; 2023 c.593 §11]